Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Administration of an Intravenous Fat Emulsion Enriched with Medium-Chain Triglyceride/ω-3 Fatty Acids is Beneficial Towards Anti-Inflammatory Related Fatty Acid Profile in Preterm Neonates: A Randomized, Double-Blind Clinical Trial.
Papandreou P, Gioxari A, Ntountaniotis D, Korda ON, Skouroliakou M, Siahanidou T. Papandreou P, et al. Among authors: ntountaniotis d. Nutrients. 2020 Nov 16;12(11):3526. doi: 10.3390/nu12113526. Nutrients. 2020. PMID: 33207743 Free PMC article. Clinical Trial.
Nutrition-drug interactions: a Web-based approach to pharmaceutical care in Greece.
Skouroliakou M, Thanopoulos MN, Maravelias G, Papandreou P, Ntountaniotis D, Daskalou E, Karagiozoglou-Lampoudi T. Skouroliakou M, et al. Among authors: ntountaniotis d. J Am Pharm Assoc (2003). 2014 Jul-Aug;54(4):419-26. doi: 10.1331/JAPhA.2014.13194. J Am Pharm Assoc (2003). 2014. PMID: 24952640
Investigation of the interactions of silibinin with 2-hydroxypropyl-β-cyclodextrin through biophysical techniques and computational methods.
Kellici TF, Ntountaniotis D, Leonis G, Chatziathanasiadou M, Chatzikonstantinou AV, Becker-Baldus J, Glaubitz C, Tzakos AG, Viras K, Chatzigeorgiou P, Tzimas S, Kefala E, Valsami G, Archontaki H, Papadopoulos MG, Mavromoustakos T. Kellici TF, et al. Among authors: ntountaniotis d. Mol Pharm. 2015 Mar 2;12(3):954-65. doi: 10.1021/mp5008053. Epub 2015 Feb 19. Mol Pharm. 2015. PMID: 25665128
Rational drug design paradigms: the odyssey for designing better drugs.
Kellici T, Ntountaniotis D, Vrontaki E, Liapakis G, Moutevelis-Minakakis P, Kokotos G, Hadjikakou S, Tzakos AG, Afantitis A, Melagraki G, Bryant S, Langer T, Di Marzo V, Mavromoustakos T. Kellici T, et al. Among authors: ntountaniotis d. Comb Chem High Throughput Screen. 2015;18(3):238-56. doi: 10.2174/1386207318666150305125638. Comb Chem High Throughput Screen. 2015. PMID: 25747445 Review.
Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor.
Kellici TF, Ntountaniotis D, Kritsi E, Zervou M, Zoumpoulakis P, Potamitis C, Durdagi S, Salmas RE, Ergun G, Gokdemir E, Halabalaki M, Gerothanassis IP, Liapakis G, Tzakos A, Mavromoustakos T. Kellici TF, et al. Among authors: ntountaniotis d. Curr Med Chem. 2016;23(1):36-59. doi: 10.2174/0929867323666151117122116. Curr Med Chem. 2016. PMID: 26572611 Review.
29 results